Product Information

CARVEDILOL 12.5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0214 per EA under NDC 72888003601. Its NADAC has been published 217 times since Jun 29, 2022.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 12.5 MG TABLET

CARVEDILOL
$0.0214per EA

Strength

12.5 mg/1

NDC

72888003601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078165

FDA Approved

9/5/2007

TE Code

AB

On Market Since

7/29/2021

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 12.5 MG TABLET has been published 217 times since Jun 29, 2022, and over the history we have for it it has declined 10.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0214 per EA
All-time high$0.0245 (Aug 10, 2022)
All-time low$0.0184 (Nov 20, 2024)
52-week high$0.0217
52-week low$0.0209
Median price$0.0220
Average price$0.0220
Largest weekly change-18.1% (Nov 20, 2024)
Weeks tracked217
Tracking sinceJun 29, 2022

Price History

1W

+2.1%

1M

+2.1%

3M

+1.7%

6M

+2.4%

1Y

-1.3%

3Y

-4.3%

5Y

N/A

All

-10.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CARVEDILOL 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 12.5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0214 per EA (NDC 72888003601), effective Aug 19, 2026.

How has the price of CARVEDILOL 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 12.5 MG TABLET has declined 10.5%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 12.5 MG TABLET?

Since Jun 29, 2022, the NADAC for CARVEDILOL 12.5 MG TABLET has ranged from a low of $0.0184 (Nov 20, 2024) to a high of $0.0245 (Aug 10, 2022), with a median of $0.0220 per EA.

Are there cheaper alternatives to CARVEDILOL 12.5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 12.5 MG TABLET?

CARVEDILOL 12.5 MG TABLET (NDC 72888003601) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.